Fieldview Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,229
Closed -$875K 619
2025
Q4
$875K Buy
+4,229
New +$836K 0.15% 202
2025
Q1
Sell
-2,238
Closed -$324K 501
2024
Q4
$324K Buy
+2,238
New +$347K 0.05% 346

Other funds holding JNJ

Fieldview Capital Management's JNJ Position: Q1 2026 in Review

Fieldview Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 4,229 shares — an estimated $875K sold.

Fieldview Capital Management first reported a position in JNJ in Q4 2024 and held it in 2 quarters. The position peaked at $875K in Q4 2025. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fieldview Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 4,229 Johnson & Johnson shares in Q1 2026, an estimated $875K.
  • Fieldview Capital Management first reported a position in Johnson & Johnson in Q4 2024 and held it in 2 quarters.
  • Fieldview Capital Management's Johnson & Johnson position peaked at $875K in Q4 2025.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.